Загрузка...
Achievements and future developments of ALK-TKIs in the management of CNS metastases from ALK-positive NSCLC
Non-small cell lung cancer (NSCLC) represents the paradigm of personalized treatment of human cancer. Several oncogenic druggable alterations have been so far identified, with anaplastic lymphoma kinase (ALK) gene rearrangements being one of the newest and most appealing. Presence of ALK fusions is...
Сохранить в:
| Опубликовано в: : | Transl Lung Cancer Res |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AME Publishing Company
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5233871/ https://ncbi.nlm.nih.gov/pubmed/28149753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2016.12.05 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|